FDA releases guidance on clinical trials backing PMA applications

08/17/2011 | MassDevice.com (Boston)

The FDA has issued another guidance outlining the basic features of clinical trials designed to support medical devices seeking premarket approval, which will be up for comment over the next three months. The guidance, which may also be applicable to 510(k) submissions, "will help manufacturers and researchers better understand the FDA's basic expectations for clinical trials," said Dr. Jeffrey Shuren, director of the FDA's device center.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC